Last reviewed · How we verify
NCT02748278
Comparison of the Number of Oocytes Obtained Between Chinese and Caucasian Women in IVF Treatment
trial testing Transvaginal ultrasound-guided oocyte retrieval in Subfertility in 192 participants. Completed in 30 December 2020.
30 April 2020
Quick facts
| Lead sponsor | The University of Hong Kong |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 192 |
| Start date | 1 October 2016 |
| Primary completion | 30 April 2020 |
| Estimated completion | 30 December 2020 |
| Sites | 1 location across China |
Drugs / interventions tested
- Transvaginal ultrasound-guided oocyte retrieval
- Embryo transfer
Conditions studied
- Subfertility — all drugs for Subfertility →
Sponsor
The University of Hong Kong
Who can join
Adults 18 to 40, female only, with Subfertility. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
IVF is a well-established method to treat various causes of infertility. Some studies have suggested that ethnicity affects the success of IVF. This is a prospective study involving two tertiary IVF units in Hong Kong and Australia. The IVF outcome between Chinese and Caucasians will be compared.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Comparison of the number of oocytes obtained after ovarian stimulation between Chinese and Caucasian women undergoing in vitro fertilization using a standardized stimulation regime.
Ko JKY, Kan A, Leung P, Lee VCY, et al · · 2021 · cited 3× · PMID 34895264 · DOI 10.1186/s13048-021-00928-4
Verify or expand the search:
- PubMed search for NCT02748278
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Subfertility
Currently open trials in the same condition.
- NCT07375238 — Effect of Daily Intake of Gazpacho on Semen Quality and Oxidative Stress · NA · recruiting
- NCT05876234 — The Predictive Value of Progesterone · active not recruiting
- NCT05328999 — Fertility and the Microbiome · recruiting
- NCT03859921 — Oral Dydrogesterone as Luteal Phase Support in Natural Cycle FET · Phase 3 · recruiting
- NCT04064840 — GnRH Agonist for Dual Trigger in IVF and for Luteal Phase Support in FET · Phase 3 · recruiting
Other The University of Hong Kong trials
Trials by the same sponsor.
- NCT05981430 — Fecal Microbiota Transplantation for Decolonization of Carbapenem-resistant Enterobacteriaceae · NA · not yet recruiting
- NCT07478757 — Assessing the Effectiveness of Low-Dose Computed Tomography in Lung Cancer Screening for High-Risk Smokers: A Randomized · NA · not yet recruiting
- NCT07448649 — Chatbot-Assisted Advance Care Planning Education for Family Members · NA · not yet recruiting
- NCT07484932 — TRTRM (ACTTOP) -Guided Dosing Strategy in Older Patients With Cancer · NA · not yet recruiting
- NCT07531589 — BrainLive Connect: Non-professional Delivered CST for People Living With Dementia · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02748278 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The University of Hong Kong
- Last refreshed: 29 April 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02748278.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing